HEADER ANTIBACTERIAL AND ANTITUMOR PROTEIN 13-JUL-93 1NCO TITLE STRUCTURE OF THE ANTITUMOR PROTEIN-CHROMOPHORE COMPLEX TITLE 2 NEOCARZINOSTATIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: HOLO-NEOCARZINOSTATIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CARZINOSTATICUS; SOURCE 3 ORGANISM_TAXID: 1897 KEYWDS ANTIBACTERIAL AND ANTITUMOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.-H.KIM,B.-M.KWON,A.G.MYERS,D.C.REES REVDAT 3 05-JUN-24 1NCO 1 REMARK REVDAT 2 24-FEB-09 1NCO 1 VERSN REVDAT 1 31-OCT-93 1NCO 0 JRNL AUTH K.H.KIM,B.M.KWON,A.G.MYERS,D.C.REES JRNL TITL CRYSTAL STRUCTURE OF NEOCARZINOSTATIN, AN ANTITUMOR JRNL TITL 2 PROTEIN-CHROMOPHORE COMPLEX. JRNL REF SCIENCE V. 262 1042 1993 JRNL REFN ISSN 0036-8075 JRNL PMID 8235619 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1556 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.014 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 2.840 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NCO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.50000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 26.25000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 8.75000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 43.75000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE GENERAL NON-CRYSTALLOGRAPHIC TWO-FOLD AXIS BETWEEN TWO REMARK 300 MOLECULES IN THE ASYMMETRIC UNIT WAS DETERMINED BY DENSITY REMARK 300 CORRELATION STUDIES AND MANUAL MOLECULAR REPLACEMENT WITH REMARK 300 MACROMOMYCIN STRUCTURE AS A MODEL. REMARK 300 REMARK 300 THE MOLECULE PREFIXED WITH "B" IS THE HOLO-NEOCARZINOSTATIN REMARK 300 AND THE MOLECULE WITH "A" IS THE APO-NEOCARZINOSTATIN. THE REMARK 300 CURRENT MODEL HAS 226 RESIDUES OF MOLECULES A AND B, 1 REMARK 300 NEOCARZINOSTATIN-CHROMOPHORE, 1 MPD AND 161 WATER MOLECULES REMARK 300 (1773 NON-HYDROGEN ATOMS TOTAL ). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP B 39 CG TRP B 39 CD2 -0.103 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 39 CB - CG - CD1 ANGL. DEV. = -7.9 DEGREES REMARK 500 TRP A 39 NE1 - CE2 - CZ2 ANGL. DEV. = -7.9 DEGREES REMARK 500 TRP A 39 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 TRP A 39 CG - CD2 - CE3 ANGL. DEV. = 6.1 DEGREES REMARK 500 ARG A 82 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 82 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 TRP A 83 CD1 - CG - CD2 ANGL. DEV. = 7.4 DEGREES REMARK 500 TRP A 83 CG - CD1 - NE1 ANGL. DEV. = -6.1 DEGREES REMARK 500 TRP A 83 CE2 - CD2 - CG ANGL. DEV. = -5.7 DEGREES REMARK 500 THR A 90 CA - CB - OG1 ANGL. DEV. = -12.6 DEGREES REMARK 500 THR A 90 CA - CB - CG2 ANGL. DEV. = 8.4 DEGREES REMARK 500 LEU A 97 CA - CB - CG ANGL. DEV. = 20.7 DEGREES REMARK 500 TRP B 39 CD1 - CG - CD2 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG B 70 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 82 NE - CZ - NH1 ANGL. DEV. = 6.5 DEGREES REMARK 500 ARG B 82 NE - CZ - NH2 ANGL. DEV. = -8.2 DEGREES REMARK 500 TRP B 83 CD1 - CG - CD2 ANGL. DEV. = 7.3 DEGREES REMARK 500 TRP B 83 CG - CD1 - NE1 ANGL. DEV. = -6.2 DEGREES REMARK 500 TRP B 83 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 48 74.46 -104.83 REMARK 500 ASN B 48 71.55 -111.01 REMARK 500 ASP B 58 -169.69 -72.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHR B 114 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD A 114 DBREF 1NCO A 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 1NCO B 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 SEQRES 1 A 113 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 A 113 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 A 113 GLN ALA GLY THR ALA TYR ASP VAL GLY GLN CYS ALA TRP SEQRES 4 A 113 VAL ASP THR GLY VAL LEU ALA CYS ASN PRO ALA ASP PHE SEQRES 5 A 113 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 A 113 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 A 113 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 A 113 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 A 113 PRO GLU GLY VAL ALA ILE SER PHE ASN SEQRES 1 B 113 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 B 113 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 B 113 GLN ALA GLY THR ALA TYR ASP VAL GLY GLN CYS ALA TRP SEQRES 4 B 113 VAL ASP THR GLY VAL LEU ALA CYS ASN PRO ALA ASP PHE SEQRES 5 B 113 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 B 113 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 B 113 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 B 113 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 B 113 PRO GLU GLY VAL ALA ILE SER PHE ASN HET MRD A 114 8 HET CHR B 114 48 HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM CHR NEOCARZINOSTATIN-CHROMOPHORE HETSYN CHR NCS-CHROMOPHORE FORMUL 3 MRD C6 H14 O2 FORMUL 4 CHR C35 H33 N O12 FORMUL 5 HOH *161(H2 O) HELIX 1 1 PRO A 49 PHE A 52 5 4 HELIX 2 2 PRO B 49 PHE B 52 5 4 SHEET 1 A 3 THR A 4 THR A 8 0 SHEET 2 A 3 VAL A 18 ALA A 24 -1 N LYS A 20 O THR A 8 SHEET 3 A 3 ALA A 63 THR A 68 -1 O ALA A 63 N GLY A 23 SHEET 1 B 4 VAL A 108 ALA A 109 0 SHEET 2 B 4 CYS A 93 SER A 98 -1 O VAL A 95 N VAL A 108 SHEET 3 B 4 ALA A 31 ASP A 41 -1 N ASP A 33 O SER A 98 SHEET 4 B 4 VAL A 44 CYS A 47 -1 O VAL A 44 N VAL A 40 SHEET 1 C 4 VAL A 108 ALA A 109 0 SHEET 2 C 4 CYS A 93 SER A 98 -1 O VAL A 95 N VAL A 108 SHEET 3 C 4 ALA A 31 ASP A 41 -1 N ASP A 33 O SER A 98 SHEET 4 C 4 SER A 53 THR A 56 -1 N SER A 53 O VAL A 34 SHEET 1 D 2 SER A 72 PHE A 76 0 SHEET 2 D 2 ARG A 82 ASP A 87 -1 N TRP A 83 O GLY A 75 SHEET 1 E 3 THR B 4 THR B 8 0 SHEET 2 E 3 VAL B 18 ALA B 24 -1 N LYS B 20 O THR B 8 SHEET 3 E 3 ALA B 63 THR B 68 -1 O ALA B 63 N GLY B 23 SHEET 1 F 4 VAL B 108 ALA B 109 0 SHEET 2 F 4 CYS B 93 SER B 98 -1 O VAL B 95 N VAL B 108 SHEET 3 F 4 ALA B 31 ASP B 41 -1 N ASP B 33 O SER B 98 SHEET 4 F 4 VAL B 44 CYS B 47 -1 N VAL B 44 O ASP B 41 SHEET 1 G 4 VAL B 108 ALA B 109 0 SHEET 2 G 4 CYS B 93 SER B 98 -1 O VAL B 95 N VAL B 108 SHEET 3 G 4 ALA B 31 ASP B 41 -1 N ASP B 33 O SER B 98 SHEET 4 G 4 SER B 53 THR B 56 -1 O SER B 53 N VAL B 34 SHEET 1 H 2 SER B 72 PHE B 76 0 SHEET 2 H 2 ARG B 82 ASP B 87 -1 N TRP B 83 O GLY B 75 SSBOND 1 CYS A 37 CYS A 47 1555 1555 2.02 SSBOND 2 CYS A 88 CYS A 93 1555 1555 1.98 SSBOND 3 CYS B 37 CYS B 47 1555 1555 2.02 SSBOND 4 CYS B 88 CYS B 93 1555 1555 1.99 CISPEP 1 THR A 8 PRO A 9 0 -8.02 CISPEP 2 THR B 8 PRO B 9 0 -9.43 SITE 1 AC1 19 ALA A 1 THR A 90 GLY B 35 CYS B 37 SITE 2 AC1 19 TRP B 39 LEU B 45 CYS B 47 PRO B 49 SITE 3 AC1 19 PHE B 52 PHE B 76 LEU B 77 PHE B 78 SITE 4 AC1 19 GLY B 80 GLN B 94 VAL B 95 GLY B 96 SITE 5 AC1 19 SER B 98 ALA B 100 GLY B 102 SITE 1 AC2 8 GLY A 35 CYS A 37 LEU A 45 GLN A 94 SITE 2 AC2 8 VAL A 95 GLY A 96 LEU A 97 SER A 98 CRYST1 90.400 90.400 52.500 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011062 0.006387 0.000000 0.00000 SCALE2 0.000000 0.012773 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019048 0.00000